Founded in 2014, Kono Chem Co., Ltd is an export-oriented production enterprise supported by the State Department of Commerce.
Kono Chem covers an area of 312,000 square meters, with scientific and technological personnel accounting for more than 35%. The headquarter of the company is located in Xi'an, Shaanxi Province. It consists of two chemical fermentation workshops, a pilot-scale reaction workshop and a provincial R&D center. Since the establishment of the company, it has been recognized by customers at home and abroad and audited by authoritative laboratories in accordance with ISO9000, ISO14001 and specifications. At present, the company's main products involve biopharmaceuticals, flavors and fragrances, pesticide intermediates, veterinary drug development, and some custom synthesis.

With comprehensive EHS management and high-quality advantages, Kono Chem sells 85% of its products in more than 50 countries around the world, and has established long-term strategic partnerships with multinational companies such as CIPLA, BIOCON, and DSM. The company adheres to the business tenet of "integrity and diligence", with an efficient research and development system, simple and diligent employees, and a responsible corporate culture, and sincerely invites domestic and foreign colleagues who are willing to cooperate for a long time to join the mission for the development of the chemical raw material industry.

Cabergoline, commonly known in the community as Caber, is a dopamine agonist used to lower levels of prolactin in the body. It is used by many athletes to combat elevated prolactin levels in drugs such as daika and trenbolone. This is especially important for people who are prolactin-sensitive and want to avoid the annoying side effects that often come from these compounds.

Cabergoline, an ergot alkaloid derivative, is a dopamine receptor agonist with a similar effect to bromocriptine. It is characterized by strong, long-acting and selective, and D2 dopamine receptors have a high affinity. And has a strong and lasting effect of inhibiting the secretion of mammary glands. This product is easy to be absorbed, the peak plasma concentration time is 1 to 3 hours, the plasma protein binding rate is 40%, and the half-life is 63 to 100 hours. This product is extensively metabolized by hydrolysis and excreted mainly in bile and feces. Mainly used for Parkinson's disease, Parkinson's syndrome, hyperprolactinemia. This product can reduce the severity of the "on-off phenomenon" caused by long-term use of levodopa.

1. For early and late Parkinson's disease;
2. Hyperprolactinemia caused by primary and deviated pituitary tumors;
3. Inhibit physiological lactation and treat hyperprolactinemia-related diseases.